The "Cocaine Intoxication - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering.
The report delivers an in-depth understanding of the Cocaine Intoxication, historical and forecasted epidemiology in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
As the market is derived using the patient-based model, the Cocaine Intoxication epidemiology chapter in the report provides historical as well as forecasted epidemiology segmented by Total Emergency Visits due to Cocaine, in the 7MM covering the United States, EU4 countries (Germany, France, Italy, and Spain) and the United Kingdom, and Japan, from 2020 to 2034. As per estimations, total emergency visits due to Cocaine in the 7MM were approximately 970 thousand cases in 2022 and these cases are projected to increase during the forecast period.
KOL Views
To gaze into the epidemiology insights of the real world, we take KOLs and SMEs' opinions working in the domain through primary research to fill the data gaps and validate the secondary research.
Industry Experts were contacted for insights on Cocaine Intoxication evolving treatment landscape, patient reliance on conventional therapies, patient therapy switching acceptability, along with challenges related to accessibility, including KOL from Mayo Medical School, Rochester, Minnesota, United States; Institute fur Therapieforschung, Munchen, Germany; Department of Medical Pharmacology and Toxicology, Center for Addictovigilance, Univ Montpellier, Montpellier, France; University of Rome Tor Vertaga, Italy; Emergency Department, Hospital Clinic, Barcelona, Spain; Faculty of Life Sciences and Medicine, King's College London, London; Pharmaceutical and Food Safety Bureau, Ministry of Health, Labor and Welfare, Tokyo and others.
Key Highlights
- The analyst projects that among the total Emergency Visits due to Cocaine in 7MM approximately 55% of cases were from the US, in 2022. The cases are expected to rise in the forecast period, due to factors such as heightened availability of cocaine, changes in societal norms and behaviors, and potentially increased stressors leading to substance abuse.
- As per the analysis, in 2022, the EU4 and the UK accounted for nearly 308 thousand cases of total emergency visits due to Cocaine, out of which Spain recorded the highest cases, that is nearly 108 thousand cases while Germany recorded the lowest, with nearly 8 thousand cases.
- The total emergency visits due to cocaine, in the United States were estimated to be approximately 550 thousand in 2022, and it is expected to increase at an estimated CAGR throughout the study period (2020-2034).
- EU4 and the UK accounted for nearly 307 thousand cases of total emergency visits due to cocaine. Among EU4 and the UK, the United Kingdom recorded around 61 thousand cases of total emergency visits due to cocaine and these cases are expected to increase during the forecast period (2023-2034).
- In Japan, there were around 123 thousand cases of the total emergency visits due to Cocaine, in 2022. Japan accounted around 13% of total emergency visits due to cocaine, in the 7MM. It is anticipated that these numbers will decrease over the study period due to a declining population trend in Japan.
Scope of the Report
- The report covers a segment of key events, an executive summary, descriptive overview of Cocaine Intoxication, explaining its causes, signs and symptoms, and pathogenesis.
- Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of diagnosis rate, disease progression, and guidelines.
- The report provides an edge for understanding trends, expert insights/KOL views, and patient journeys in the 7MM.
- A detailed review of current challenges in establishing the diagnosis.
Cocaine Intoxication Report Insights
- Patient Population
- Country-wise Epidemiology Distribution
- Total Emergency Visits due to Cocaine
Cocaine Intoxication Report Key Strengths
- 12 years Forecast
- The 7MM Coverage
- Cocaine Intoxication Epidemiology Segmentation
Key Topics Covered:
1. Key Insights
2. Report Introduction
3. Cocaine Intoxication Patient Epidemiology Overview at a Glance
3.1. Patient Share (%) of Cocaine Intoxication in 2020
3.2. Patient Share (%) of Cocaine Intoxication in 2034
4. Disease Background and Overview: Cocaine Intoxication
4.1. Introduction of Cocaine Intoxication
4.2. Etiology of Cocaine Intoxication
4.3. Cause and Symptoms of Cocaine Intoxication
4.4. Life-threatening Complications associated to Cocaine Intoxication
4.5. Stages of Cocaine Intoxication
4.6. Pathophysiology of Cocaine Intoxication
4.7. Diagnostic Approach for Cocaine Intoxication
4.7.1. Diagnostic Guidelines
4.7.1.1. DSM-5 criteria
5. Epidemiology and Patient Population
5.1. Key Findings
5.2. Methodology of Epidemiology
5.3. Assumptions and Rationale: 7MM
5.4. Total Emergency Visits due to Cocaine in the 7MM
5.5. The United States
5.5.1. Total Emergency Visits due to Cocaine in the United States
5.6. EU4 and the UK
5.6.1. Total Emergency Visits due to Cocaine in Germany
5.6.2. Total Emergency Visits due to Cocaine in France
5.6.3. Total Emergency Visits due to Cocaine in Italy
5.6.4. Total Emergency Visits due to Cocaine in Spain
5.6.5. Total Emergency Visits due to Cocaine in the UK
5.7. Japan
5.7.1. Total Emergency Visits due to Cocaine in Japan
6. Patient Journey
7. Key Opinion Leaders' Views
8. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/wf3nti
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250414276065/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900